Market Outlook

By 2035, the U.S. Single-Use Surgical Instruments Market is expected to reach approximately USD 3.65 billion, expanding at a CAGR of 7.80% during the forecast period 2026–2035. The market was valued at approximately USD 1.72 billion in 2025, with historical analysis covering 2021–2024. Values throughout this report are expressed in USD billions. The 2025 market benchmark is consistent with published U.S.-specific disposable surgical device estimates, which place the market at approximately USD 1.72 billion and indicate a 7.8% medium-term growth trajectory.

The U.S. single-use surgical instruments industry is transitioning from a category historically dominated by low-complexity disposable scalpels, blades, forceps, scissors, trocars, and procedure accessories into a broader perioperative technology segment. Hospitals and ambulatory surgery centers are increasingly evaluating single-use devices through the combined lenses of sterility assurance, operating room productivity, sterile processing capacity, instrument consistency, supply availability, procedure economics, and clinician preference. The addressable market now includes conventional handheld instruments as well as single-use electrosurgical devices, advanced laparoscopic tools, endoscopic instruments, specialty procedure kits, disposable visualization products, and emerging powered instruments.

Patient-safety economics remain fundamental to adoption. CDC data indicate that on any given day approximately one in 31 U.S. hospital patients has at least one healthcare-associated infection. Although single-use instruments cannot independently eliminate surgical-site infections or other HAIs, removing certain instruments from the reprocessing cycle can reduce one potential source of cleaning, sterilization, handling, and instrument-integrity variability. The FDA has also emphasized that inadequate reprocessing of reusable medical devices can allow biological debris or microorganisms to remain on devices and potentially contribute to adverse outcomes.

The market expanded from an estimated USD 1.30 billion in 2021 to USD 1.60 billion in 2024, before reaching approximately USD 1.72 billion in 2025. Historical growth reflected normalization of elective surgery after the pandemic, sustained migration of procedures into outpatient settings, increasing adoption of minimally invasive surgery, sterile-processing labor pressure, and greater acceptance of procedure-specific disposable kits. Over 2026–2035, expansion is expected to become increasingly value-driven rather than simply infection-control driven, with hospitals comparing the acquisition cost of disposables against the full lifecycle cost of reusable instruments.

A defining characteristic of the U.S. market is the scale of its procedural infrastructure. The United States has approximately 6,100 hospitals, more than 907,000 staffed hospital beds and about 35.7 million annual hospital admissions, while federal outpatient payment policy affects approximately 6,000 ambulatory surgical centers. This creates an unusually large installed base of operating rooms, procedure rooms, specialty surgical centers, emergency departments and outpatient facilities that consume sterile surgical products every day.

From 2026 through 2035, the strongest commercial opportunities will be concentrated in instruments where reprocessing is difficult, instrument degradation can materially affect performance, immediate availability creates operating room value, or procedure volumes are sufficiently standardized to support preconfigured disposable sets. Single-use instruments will not replace reusable stainless-steel instrumentation across the entire surgical workflow. Instead, the market will increasingly develop as a hybrid environment in which hospitals retain durable reusable platforms for economically appropriate categories while converting selected high-risk, high-turnover, delicate, complex, or workflow-sensitive instruments to single-use formats.

Introduction

According to the U.S. Single-Use Surgical Instruments Market Report, demand is being reshaped by structural changes in American surgery rather than by disposability alone. The most important transition is the migration of procedures from traditional inpatient operating rooms toward hospital outpatient departments, ambulatory surgery centers and specialty procedure facilities. These environments place a premium on predictable setup, rapid room turnover, reduced dependence on centralized sterile processing, compact inventory requirements, and consistent instrumentation.

Single-use surgical instruments are designed for use on one patient during one procedure and are typically supplied sterile and ready for use. Depending on the specialty and product definition, the category includes scalpels, forceps, scissors, retractors, needle holders, clamps, dissectors, biopsy instruments, electrosurgical tools, trocars, graspers, laparoscopic scissors, suction-irrigation products, specialty endoscopic devices and procedure-specific instrumentation. More sophisticated products are extending the concept into disposable imaging systems, powered surgical tools and integrated instruments incorporating electronics or energy delivery.

The distinction between single-use and reusable instrumentation is especially important in U.S. procurement. Reusable instruments require acquisition, inventory management, transportation, cleaning, inspection, maintenance, sterilization, packaging, tracking and replacement. FDA guidance describes reprocessing as a detailed, multistep process and notes that it is labor-intensive and time-consuming. By contrast, single-use products shift a greater proportion of lifecycle cost into the original purchase price while reducing or eliminating several downstream processing requirements.

This does not mean single-use products automatically have superior economics. High procedure volumes can make reusable instrumentation cost-effective when sterilization capacity is efficient and instrument life is long. Conversely, the economics can favor disposables when devices are easily damaged, difficult to clean, infrequently used, distributed across multiple satellite facilities, or responsible for disproportionate reprocessing labor. Procurement decisions therefore increasingly require a total-cost-of-ownership model rather than a direct comparison between the price of a disposable device and the acquisition cost of a reusable equivalent.

Regulatory considerations are equally important. The FDA defines a single-use device as one intended for one use or for use on a single patient during a single procedure. When devices labeled for single use are reprocessed, FDA requirements apply to reprocessors, including appropriate validation, labeling and postmarket obligations. This regulatory framework reinforces the importance of validated device lifecycle claims and clear differentiation among original single-use products, FDA-regulated reprocessed devices, and reusable products.

The next phase of market development will be determined by whether manufacturers can prove that disposability creates measurable clinical or operating value. Winning products will increasingly need to demonstrate dependable sharpness, grasping force, energy delivery, visualization quality, ergonomic performance, sterile availability, lower repair exposure, reduced processing requirements or faster operating room turnover. Environmental impact will simultaneously become a stronger purchasing criterion, encouraging manufacturers to reduce packaging, improve material efficiency, introduce recycling pathways, and develop lower-carbon manufacturing and logistics models.

Key Market Drivers: What’s Fueling the U.S. Single-Use Surgical Instruments Market Boom?

The first major driver is the continued focus on infection prevention and instrument reprocessing quality. U.S. hospitals have made significant progress in reducing several healthcare-associated infections, yet CDC surveillance continues to demonstrate that HAIs remain a material patient-safety issue. In 2024, acute-care hospitals recorded reductions across several monitored infections, including a 4% reduction in surgical-site infections following colon surgery, while surgical-site infections following abdominal hysterectomy increased. These mixed results reinforce the continued importance of evidence-based infection prevention across operating rooms and procedural areas.

The second major driver is expansion of outpatient surgery. ASCs are particularly attractive environments for single-use instrumentation because their operating models emphasize predictable case scheduling, fast turnover and controlled overhead. Many independent or smaller surgery centers do not have the same sterile-processing scale as large tertiary hospitals. A sterile, ready-to-use instrument can therefore remove several operational steps between receiving the product and opening it for a procedure. This advantage becomes increasingly valuable when the instrument is specialized, delicate or used in low enough volumes that maintaining reusable inventory would create unnecessary capital and processing cost.

A third growth driver is sterile-processing department capacity. Reusable surgical instruments do not return to the operating room automatically. They must move through transportation, decontamination, cleaning, inspection, assembly, packaging, sterilization, storage and redistribution. Instrument damage, incomplete sets, delayed turnaround or improper processing can affect case readiness. Selective adoption of disposable devices gives health systems another mechanism for relieving pressure on these workflows. The economic value can be particularly meaningful during peak scheduling periods, weekends, emergency procedures or staffing shortages.

Fourth, minimally invasive surgery continues to favor procedure-specific disposable technology. Modern laparoscopic and endoscopic procedures commonly require narrow-diameter instruments with mechanical, electrical, insulation or articulation components. Products such as graspers, dissectors, scissors, trocars, suction-irrigation devices and electrosurgical instruments may experience wear that affects precision or electrical integrity over repeated cycles. Single-use configurations offer manufacturers the ability to guarantee defined performance characteristics for every case without accounting for prior handling or sterilization history.

Fifth, hospital procurement practices increasingly emphasize total procedure economics. Large integrated delivery networks evaluate not only device acquisition price but also sterile-processing labor, instrument replacement, repair, tray assembly time, storage requirements, lost instruments, procedure delays, infection-prevention implications and OR utilization. This is creating opportunities for manufacturers able to present credible health-economic models demonstrating when a disposable instrument produces a lower cost per completed case even when its unit price is higher.

A sixth driver is the increasing sophistication of disposable technology. Single-use instrumentation is moving beyond commodity scissors and forceps. The FDA cleared the Peleton Universal Single Use Power System in April 2024 for applications involving drilling, reaming, pin and wire placement and cutting of bone and hard tissue. The system demonstrates how disposable surgical technology is moving into categories previously associated primarily with reusable capital-linked instrumentation.

A seventh driver is supply standardization. Procedure-specific packs and single-use kits can reduce variation in instrument selection and improve availability across multi-site health systems. Standardization is particularly attractive for repetitive procedures performed across community hospitals, ASCs and specialty clinics. Manufacturers that combine instruments into clinically designed kits can potentially capture a greater proportion of spending per procedure while simplifying purchasing and inventory management for providers.

Finally, U.S. demographics continue to support surgical volumes. An aging population increases demand across orthopedics, ophthalmology, cardiovascular surgery, urology and general surgery. Rising prevalence of obesity, diabetes, musculoskeletal disease and cancer increases the number of patients entering procedural pathways. Single-use instrument manufacturers therefore benefit indirectly from the broader increase in surgical utilization while gaining additional share from conversion away from selected reusable instruments.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in single-use instruments is increasingly centered on making disposable devices perform like premium reusable instruments. Historically, surgeons sometimes associated disposables with lower tactile quality or limited durability. Manufacturers are addressing this by improving metallurgy, polymer engineering, jaw geometry, cutting-edge consistency, handle ergonomics, insulation, articulation and manufacturing tolerances. The strategic objective is to remove performance as a reason for clinicians to reject single-use conversion.

Single-use electrosurgical instruments represent one of the most attractive areas of innovation. Bipolar forceps, monopolar devices, vessel-sealing instruments and laparoscopic energy tools can combine mechanical action with electrical functionality. Because insulation integrity and electrode performance are essential to safe use, consistency from case to case can carry significant value. Manufacturers that combine predictable energy delivery with ergonomic design and competitive per-procedure economics are positioned to capture share.

Integrated disposable visualization is another emerging category. Pristine Surgical’s Summit platform demonstrates the direction of this market with a sterile single-use digital arthroscope incorporating a camera, LED illumination and irrigation components. The broader commercial implication is important: disposable instruments are evolving from passive mechanical devices into digitally enabled procedure technologies.

Powered disposable surgical instruments represent a further innovation frontier. The FDA-cleared Peleton system includes a battery-driven tool for orthopedic, trauma and related procedures and incorporates technology allowing the device to remain sterile while being charged through its sterile barrier. Such designs illustrate how manufacturers can transfer functions traditionally linked to reusable powered equipment into ready-to-use sterile formats.

Procedure-specific kit engineering is also advancing. Instead of selling an isolated disposable forceps or scalpel, suppliers are increasingly designing instrument assortments around specific clinical workflows. A well-designed kit can reduce case picking, simplify inventory, decrease unopened excess supplies and provide standardized availability across facilities. This model is particularly relevant to ophthalmology, ENT, minor orthopedics, gynecology and office-based surgical procedures.

Sustainability will become a central innovation requirement through 2035. The greatest commercial risk facing the disposable model is the perception that clinical convenience comes at the expense of healthcare waste. Manufacturers are responding through reduced packaging volume, recyclable materials, take-back programs, material substitution and more efficient sterilization and logistics. Hospitals are likely to become increasingly sophisticated in distinguishing products that merely shift costs away from sterile processing from products that genuinely improve the combined clinical, economic and environmental performance of a procedure.

Quality systems will also influence innovation strategy. The FDA’s Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into the U.S. device quality framework. For single-use manufacturers managing high-volume production, sterilization validation, packaging integrity and global supply chains, disciplined risk management and quality-system execution will remain critical competitive capabilities.

Segmentation Insights

The U.S. Single-Use Surgical Instruments Market is segmented on the basis of product type, application, end user, sales and distribution model, and geography.

By Product Type

• Handheld single-use surgical instruments represent one of the largest and most established segments. Products include disposable scalpels, blades, scissors, forceps, clamps, retractors, needle holders, curettes, biopsy instruments and specialty handheld devices. Demand is particularly strong where sharpness, cleanliness or dimensional consistency is important and where a reusable alternative would require disproportionately expensive processing. The category also benefits from straightforward distribution through hospital supply chains and procedure packs.
• Single-use electrosurgical instruments are expected to be among the fastest-growing product categories through 2035. The segment includes disposable bipolar forceps, monopolar instruments, electrosurgical pencils, laparoscopic electrodes, vessel-sealing instruments and related energy-delivery tools. Electrosurgical products command higher average selling prices than basic handheld instruments and can generate recurring procedure-based revenue. Growth is being reinforced by minimally invasive surgery and by provider preference for products with predictable insulation, electrode and mechanical performance.
• Single-use laparoscopic and endoscopic instruments include trocars, access devices, graspers, dissectors, scissors, suction-irrigation instruments, retrieval devices, biopsy instruments and selected disposable visualization products. The expansion of laparoscopic general surgery, gynecologic surgery, bariatric procedures, urology and arthroscopy creates a large recurring demand pool. Articulation, smaller diameters, improved ergonomics and integrated visualization are expected to increase the value contribution of this segment.
• Single-use powered instruments remain a smaller revenue category but have significant long-term potential. Battery-powered drivers, drills, saws and procedure-specific powered systems can reduce dependence on reusable motors, batteries and attachments in selected cases. Adoption will initially be strongest in environments where case predictability, sterile availability and avoidance of capital or repair expense justify a higher disposable cost.
• Specialty surgical kits and other disposable instruments include procedure-specific instrument sets, microsurgical instruments, ophthalmic products, ENT instruments, obstetric and gynecologic kits, plastic surgery devices and specialized office-procedure instruments. These products create attractive opportunities for differentiation because manufacturers can optimize configurations around a particular procedure rather than compete solely on individual instrument pricing.

By Application

• General surgery represents the largest application segment because of its broad procedural base. Appendectomy, cholecystectomy, hernia repair, colorectal surgery, bariatric surgery and soft-tissue procedures use substantial volumes of single-use access devices, electrosurgical tools, scalpels, graspers, dissectors and wound-related instruments. General surgery also has significant exposure to outpatient migration, increasing the attractiveness of disposable configurations.
• Orthopedic surgery is becoming increasingly important as single-use technology expands beyond blades and basic instruments into powered tools, arthroscopy and procedure-specific instrumentation. Sports medicine and outpatient orthopedics are particularly attractive because many procedures are standardized and frequently performed in ASCs. Single-use instruments can also support smaller orthopedic facilities that cannot economically maintain the complete reusable infrastructure of a large hospital.
• Cardiovascular and thoracic surgery represent high-acuity applications in which precision and sterility are critical. Conventional open cardiovascular procedures continue to rely heavily on reusable instrumentation, but single-use electrosurgical tools, vessel-management devices, specialty scissors, access products and procedure-specific instruments create a recurring consumables opportunity.
• Obstetrics and gynecology provide a strong procedural base across hospitals, ASCs and specialty clinics. Laparoscopic hysterectomy, hysteroscopy, cesarean delivery, sterilization procedures and other gynecologic surgeries use disposable handheld, laparoscopic and electrosurgical instruments. This category is likely to benefit from continued migration of appropriate gynecologic procedures into outpatient environments.
• Urology is a growing application for disposable surgical instruments because many procedures involve narrow working channels, endoscopic access and specialized cutting, grasping or retrieval devices. Kidney stone treatment, prostate procedures, bladder interventions and minimally invasive urologic surgery support recurring use of single-use components.
• Ophthalmology, ENT, plastic surgery and other specialties collectively represent a significant opportunity. Ophthalmic surgery in particular uses very small, precision-sensitive instruments for which instrument integrity is crucial. ENT and plastic surgery also generate demand for small specialty instruments and procedure kits. These markets are commercially attractive because highly specialized single-use products may carry higher average selling prices despite lower unit volumes than general surgery.

By End User

• Hospitals and health systems remain the largest end-user segment. Large hospitals perform the widest range of procedures and account for substantial consumption of basic handheld instruments, minimally invasive devices and advanced electrosurgical products. Their purchasing decisions are increasingly centralized through system-level contracts and value-analysis committees. Vendors therefore need clinical support, contracting scale, reliable supply and credible health-economic evidence to achieve broad formulary conversion.
• The scale of this customer base is substantial. The U.S. hospital system includes approximately 6,100 facilities, with more than 3,500 community hospitals belonging to health systems. System consolidation gives large health networks greater negotiating leverage but also creates substantial opportunities: approval of a standardized single-use platform across dozens of hospitals can produce rapid volume expansion.
• Ambulatory surgery centers represent the fastest-growing strategic end-user opportunity. Approximately 6,000 ASCs are affected by the Medicare ASC payment framework, creating a large national footprint for same-day surgery. ASCs typically emphasize low overhead, efficient room turnover and predictable supply use, making ready-to-use sterile instruments particularly attractive when they eliminate capital, repair or reprocessing requirements.
• Specialty surgical hospitals and clinics are important in orthopedics, ophthalmology, ENT, gynecology and plastic surgery. These facilities frequently perform narrow ranges of highly standardized procedures, creating attractive conditions for specialty disposable kits. Manufacturers can tailor product configurations, packaging and contracting to procedure-specific economics rather than competing through a broad hospital formulary.
• Office-based procedure centers and physician practices represent a smaller but expanding segment. Dermatology, podiatry, minor plastic surgery, women’s health, ophthalmology and selected ENT procedures use disposable scalpels, scissors, forceps, biopsy instruments and preconfigured kits. These customers typically prioritize simplicity, low capital requirements, compact storage and distributor availability.

By Sales and Distribution Model

• Direct manufacturer sales dominate many premium instrument categories. Large manufacturers maintain direct commercial relationships with integrated delivery networks, academic medical centers, major ASCs and national surgical organizations. Direct contracts are particularly important for electrosurgical, advanced laparoscopic and specialty products requiring training, conversion support or portfolio-based negotiation.
• Group purchasing organization and IDN contracts play a central role in the U.S. market. Standardized purchasing agreements allow health systems to consolidate volumes, negotiate pricing and reduce supplier complexity. Single-use manufacturers must therefore demonstrate more than individual device performance; they need supply continuity, broad portfolio coverage, implementation support and data showing how conversion affects total procedure cost.
• Medical-surgical distributors remain essential for routine disposable instruments. Companies with nationwide distribution networks can aggregate thousands of SKUs and serve hospitals, ASCs and physician offices without manufacturers maintaining direct logistics relationships with every facility. Distribution reach is especially important for scalpels, blades, forceps, scissors, procedure kits and other high-volume products.
• Private-label, OEM and specialty distribution models are becoming increasingly relevant as providers look for lower-cost alternatives to established brands. Contract manufacturing also allows companies with strong hospital relationships to expand product portfolios without building every instrument internally. However, quality control, sterilization validation and supply-chain transparency will remain critical differentiators, particularly under the FDA’s updated quality-system framework.

Regional Insights: Where the Market is Growing Fastest

The U.S. Single-Use Surgical Instruments Market is geographically segmented into the South, West, Northeast and Midwest. Regional demand differs materially based on population growth, age structure, procedure volumes, hospital density, ASC penetration, physician ownership models, specialty-care concentration, hospital consolidation and adoption of advanced minimally invasive technology.

The South represents the largest regional opportunity, with an estimated market value of approximately USD 0.64 billion in 2025. The West accounts for approximately USD 0.40 billion, the Northeast approximately USD 0.37 billion, and the Midwest approximately USD 0.31 billion. Under the report’s central forecast, these markets are projected to reach roughly USD 1.39 billion, USD 0.90 billion, USD 0.77 billion and USD 0.59 billion, respectively, by 2035.

South

The South is the largest U.S. regional market and is projected to expand from approximately USD 0.64 billion in 2025 to USD 1.39 billion by 2035, representing an implied regional CAGR of approximately 8.1%. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma and Texas, together with the District of Columbia for regional commercial planning.

Texas and Florida are the most commercially important Southern state markets. Texas combines exceptional population scale with major hospital ecosystems in Houston, Dallas-Fort Worth, Austin and San Antonio. Large integrated systems, expanding suburban medical campuses and a substantial network of outpatient facilities create demand across general surgery, orthopedics, women’s health and minimally invasive procedures. The state’s geographic scale also makes sterile, standardized and distributor-supported single-use products attractive for health systems operating numerous satellite facilities.

Florida represents an especially attractive market because its large older population supports high volumes of orthopedic, ophthalmic, cardiovascular, urologic and general surgical procedures. The state’s extensive network of ASCs and specialty centers creates favorable economics for disposable instrumentation, particularly where providers are seeking to minimize sterile-processing infrastructure.

North Carolina, Georgia, Tennessee and Virginia form a second high-growth cluster. Population growth around Charlotte, Raleigh-Durham, Atlanta, Nashville, Northern Virginia and other metropolitan markets is supporting hospital expansion and outpatient surgical investment. Academic and tertiary referral institutions in these states can support early adoption of advanced disposable technologies, while community ASCs provide scale for standardized handheld and laparoscopic products.

Maryland and Delaware are smaller markets but benefit from dense healthcare infrastructure and proximity to major Mid-Atlantic referral systems. South Carolina is expanding as population migration increases healthcare utilization along major metropolitan and coastal corridors. Oklahoma and Arkansas provide steady demand through regional health systems and outpatient networks.

Alabama, Mississippi, Louisiana, Kentucky and West Virginia present a different opportunity profile. Purchasing budgets can be more cost-sensitive, and rural access remains challenging in parts of these states. Single-use suppliers therefore need to show that workflow savings offset unit-price premiums. Products capable of reducing tray complexity, minimizing capital requirements or supporting procedures in smaller facilities may have particular value.

West

The West is expected to be the fastest-growing U.S. regional market, expanding from approximately USD 0.40 billion in 2025 to USD 0.90 billion by 2035, an implied CAGR of approximately 8.4%. The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.

California is by far the largest state market in the region. Its population scale, extensive hospital infrastructure, concentration of academic medical centers and mature ASC market support significant demand for disposable surgical instrumentation. California is especially important for advanced minimally invasive products, digital surgery, disposable visualization, orthopedics and specialty surgical technology. Health systems in the state also face strong sustainability expectations, making environmental design increasingly important for single-use manufacturers.

Arizona and Nevada are high-growth opportunities because of rapid population expansion and aging demographics. Phoenix, Tucson and Las Vegas continue to attract hospital and outpatient infrastructure investment, increasing procedural capacity. These markets are well positioned for disposable instruments used in ophthalmology, orthopedics, general surgery and urology.

Washington, Oregon, Colorado and Utah are attractive for higher-value technologies. These states contain sophisticated integrated health systems with strong adoption of minimally invasive and technology-enabled surgery. Manufacturers entering these markets should expect rigorous value analysis, sustainability evaluation and demands for evidence supporting workflow benefits.

Idaho, Montana, Wyoming, Alaska, Hawaii and New Mexico are smaller markets by absolute revenue but illustrate another advantage of single-use technology. In geographically dispersed care environments, maintaining reusable specialty inventory and centralized processing logistics can be difficult. Ready-to-use instruments can support rural hospitals, critical-access facilities and smaller specialty centers where procedure frequency does not justify large reusable instrument fleets.

Northeast

The Northeast accounted for approximately USD 0.37 billion in 2025 and is projected to reach around USD 0.77 billion by 2035, representing an implied CAGR of approximately 7.6%. The region comprises Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York and Pennsylvania.

New York is the region’s largest individual market because of its population, hospital concentration and high surgical volumes. Large academic systems in New York City act as reference institutions for new surgical technologies, while suburban and upstate outpatient networks expand the recurring consumable market. Premium products generally face rigorous clinical review, but successful adoption at leading institutions can have broader commercial influence.

Massachusetts is strategically important because of its dense concentration of academic medical centers, surgical specialists and medical-device innovation. Hospitals in the Boston market are likely to evaluate new single-use technologies through detailed clinical, financial and sustainability criteria. This makes Massachusetts particularly valuable for evidence generation and early-adopter positioning rather than simply unit volume.

Pennsylvania and New Jersey offer large procedure bases and strong hospital-system concentration. Philadelphia, Pittsburgh and the densely populated New Jersey corridor create substantial opportunities for general surgical, orthopedic, gynecologic and minimally invasive disposable instruments. Large IDNs in these markets can support high-volume system-wide contracts when products meet value-analysis thresholds.

Connecticut, Rhode Island, New Hampshire, Vermont and Maine provide smaller but attractive specialty opportunities. The region’s relatively mature healthcare infrastructure means growth is more likely to come from conversion of reusable instruments, technology upgrades and outpatient migration than from major greenfield hospital capacity.

Midwest

The Midwest accounted for an estimated USD 0.31 billion in 2025 and is expected to reach approximately USD 0.59 billion by 2035, representing an implied CAGR of around 6.6%. The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota.

Illinois and Ohio are the largest Midwestern opportunities. Chicago provides a major concentration of academic and community hospitals, surgery centers and specialty practices. Ohio has several nationally influential health systems and substantial surgical capacity across Cleveland, Columbus and Cincinnati. Both markets are attractive for direct contracting with large health systems.

Michigan, Minnesota, Indiana and Wisconsin represent important secondary markets. Minnesota’s medtech ecosystem makes the state strategically relevant for innovation and clinical evaluation. Michigan and Indiana provide substantial orthopedic, cardiovascular and general surgical procedure volumes, while Wisconsin has sophisticated integrated delivery networks capable of supporting standardized purchasing across multiple facilities.

Missouri, Iowa, Kansas and Nebraska provide dependable demand from regional systems and community hospitals. Single-use conversion in these markets is likely to be strongly economics-driven, with buyers requiring demonstrable reductions in processing expense, instrument loss, capital investment or procedural delays.

North Dakota and South Dakota are smaller in absolute revenue but can benefit from the logistical simplicity of disposable instrumentation. Rural hospital networks and regional referral structures make inventory availability and standardized sterile products important. The Midwest overall is expected to grow more slowly than the South and West, but its large installed hospital infrastructure provides a stable recurring revenue base.

Key Market Players

The U.S. Single-Use Surgical Instruments competitive landscape is fragmented across global medtech manufacturers, specialist surgical-instrument suppliers, procedure-specific innovators, private-label manufacturers and national medical-surgical distributors. No single company controls the entire market because purchasing criteria differ substantially across handheld instruments, electrosurgery, laparoscopy, specialty surgery and emerging powered or visualization technologies.

Large medtech companies possess advantages in contracting, surgeon relationships, clinical education and portfolio breadth. Specialist companies compete through instrument design, procedure-specific expertise, lower overhead and faster product-development cycles. Distribution access is also highly important because many high-volume disposable instruments are purchased as part of larger medical-surgical supply contracts.

Some of the key players relevant to the U.S. Single-Use Surgical Instruments industry are:

Johnson & Johnson MedTech – Ethicon
Medtronic
BD
B. Braun
Smith+Nephew
Stryker
CONMED Corporation
CooperSurgical
Alcon
STERIS
Aspen Surgical
Integra LifeSciences
Teleflex
Olympus Corporation
Boston Scientific Corporation
Applied Medical Resources
Medline Industries
Cardinal Health
Kirwan Surgical Products
DTR Medical
Surgical Innovations Group
Pristine Surgical
Peleton Surgical
Swann-Morton

Ethicon, Medtronic, BD, B. Braun, Stryker, Smith+Nephew and CONMED have competitive advantages in established surgical relationships and broader operating-room portfolios. Their ability to bundle disposable products with other surgical technologies can influence contracting decisions at large IDNs.

Aspen Surgical, Kirwan Surgical Products, DTR Medical and other specialty suppliers compete more directly in handheld and procedure-specific instrumentation. Aspen’s current portfolio, for example, spans blades and scalpels, open-surgery instruments, electrosurgery, laparoscopic products and surgical single-use products, illustrating the increasingly broad product architecture of perioperative suppliers.

Pristine Surgical and Peleton Surgical illustrate the innovation-driven end of the market. These companies are extending single-use technology into digital arthroscopy and powered surgical instrumentation, respectively. Their commercial progress will be important for determining how far the disposable model can move beyond conventional low- and mid-value surgical instruments.

Over the forecast period, competitive differentiation will depend on sterile reliability, surgeon acceptance, manufacturing consistency, pricing, supply resilience, GPO access, procedure economics and environmental performance. Companies capable of proving that their product eliminates enough labor, processing, repair, capital or procedural inefficiency to offset disposable acquisition cost will have the strongest opportunity to convert reusable categories.

Recent Developments

The U.S. market has recently demonstrated that single-use technology can expand into higher-complexity surgical categories. In April 2024, the FDA determined the Peleton Universal Single Use Power System and Attachments to be substantially equivalent through the 510(k) pathway. The device is intended for trauma, orthopedic and related surgical applications involving drilling, reaming, placement of pins and wires and cutting bone or hard tissue. This development is strategically important because surgical power tools have traditionally been associated with reusable systems requiring cleaning, sterilization and maintenance.

Disposable surgical visualization is also gaining commercial traction. Pristine Surgical has brought its Summit single-use arthroscope to the U.S. market as a sterile digital system incorporating high-resolution visualization and disposable components. Its commercial model reflects a broader industry movement toward integrating single-use hardware with software, inventory management and service-oriented revenue models.

Infection-prevention and reprocessing capabilities are simultaneously becoming more integrated with surgical supply portfolios. In January 2026, Aspen Surgical announced the acquisition of Ruhof Healthcare, expanding its exposure to instrument reprocessing, cleaning verification, endoscopy consumables and related infection-prevention solutions. The transaction illustrates how suppliers increasingly view disposable products and reusable-device processing as complementary components of a broader perioperative workflow strategy rather than mutually exclusive markets.

Regulation changed materially in February 2026, when the FDA’s Quality Management System Regulation became effective. QMSR incorporates ISO 13485:2016 into the U.S. quality framework and introduces an updated inspection approach. For high-volume disposable instrument manufacturers, the transition increases strategic emphasis on manufacturing controls, supplier qualification, risk management, sterilization processes, packaging integrity and complaint handling.

The market is also experiencing a shift in purchasing discussions. Infection prevention remains important, but hospitals increasingly require comparative economic analysis. Vendors are being asked to quantify processing labor avoided, reusable instrument replacement rates, repair expenses, tray reduction, procedure delays and waste implications. This will favor manufacturers with sophisticated clinical-economic evidence over companies competing solely on claims of convenience.

Reprocessing of selected devices labeled for single use will remain an important counterforce. FDA-regulated third-party reprocessing allows certain SUDs to re-enter clinical use when applicable regulatory and validation requirements are met. Health systems may use reprocessing as a cost- and waste-management strategy, meaning original manufacturers must increasingly justify why a new disposable device, a reprocessed SUD or a conventional reusable solution provides the best lifecycle value for a particular procedure.

Conclusion

The U.S. Single-Use Surgical Instruments Market Size & Share is positioned to expand from approximately USD 1.72 billion in 2025 to USD 3.65 billion by 2035, representing a 7.80% CAGR during 2026–2035. Historical market expansion from approximately USD 1.30 billion in 2021 to USD 1.60 billion in 2024 reflects a transition from basic disposable instrumentation toward a more strategically important component of U.S. perioperative workflow.

The industry’s strongest growth driver will not be a wholesale replacement of reusable surgical instruments. Instead, growth will occur through selective conversion in categories where disposability can improve sterile availability, instrument consistency, processing efficiency, room turnover or total procedure economics. Handheld surgical tools will provide the largest recurring volume base, while electrosurgical devices, minimally invasive instruments, specialty kits, disposable visualization and powered single-use technology are expected to deliver disproportionately strong value growth.

Hospitals will remain the largest purchasers, but ambulatory surgery centers will represent the most strategically important growth channel. As more procedures migrate into same-day environments, manufacturers will need products designed specifically around ASC economics: minimal capital, compact inventory, predictable cost per case, fast setup and limited sterile-processing requirements.

Regionally, the South is expected to remain the largest market, increasing from approximately USD 0.64 billion in 2025 to USD 1.39 billion by 2035. Texas and Florida will be critical state markets because of population scale, procedure volume and outpatient expansion. The West is expected to record the fastest regional growth, led by California, Arizona, Washington, Colorado, Utah and Nevada. The Northeast will continue to influence premium technology adoption through academic and tertiary health systems, while the Midwest will provide a durable procedural base supported by large integrated delivery networks.

For manufacturers, distributors, investors and healthcare providers evaluating this market, the most important strategic question is not whether a surgical instrument can technically be manufactured as a disposable device. The relevant question is whether single-use design creates enough measurable clinical and operational value to justify recurring purchasing cost.

Products that simply replicate reusable instruments in disposable form will face pricing and sustainability pressure. Products that eliminate meaningful reprocessing complexity, improve clinical consistency, simplify ASC workflows, prevent procedure disruption, reduce repair requirements or enable new surgical functionality will occupy a much stronger competitive position.

The next decade will therefore transform the U.S. single-use surgical instruments industry from a predominantly consumables-oriented segment into a broader procedure-economics market. The leading companies will be those capable of combining sterile performance, manufacturing quality, supply reliability, clinician-centered design, environmental responsibility and documented total-cost-of-care advantages into a defensible value proposition for U.S. surgical providers.

TABLE OF CONTENT

1. U.S. Single-Use Surgical Instruments Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Single-Use Surgical Instrument Manufacturers
1.6.2. Medical-Grade Raw Material and Component Suppliers
1.6.3. Contract Manufacturing, Sterilization and Packaging Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory Surgery Centers and Specialty Surgical Facilities
1.6.6. Group Purchasing Organizations and Medical-Surgical Distributors
1.6.7. Surgeons, Perioperative Teams and Value Analysis Committees
1.6.8. FDA, CMS and Other Regulatory Stakeholders
1.6.9. Healthcare Sustainability and Waste-Management Stakeholders
What this section provides: This section defines the U.S. single-use surgical instruments market boundary, study scope, research methodology, assumptions, and stakeholder ecosystem so clients understand how market revenues, demand patterns, purchasing behavior, and forecasts are measured and validated.

2. U.S. Single-Use Surgical Instruments Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Single-Use versus Reusable Instrument Economics
2.8. High-Growth Opportunity Areas
2.9. Key Strategic Takeaways for Market Participants
What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, conversion from reusable to single-use instruments, competitive intensity, and priority commercial opportunities.

3. U.S. Single-Use Surgical Instruments Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Increasing Focus on Infection Prevention and Sterility Assurance
3.1.2. Expansion of Ambulatory and Outpatient Surgical Procedures
3.1.3. Growth in Minimally Invasive Surgery
3.1.4. Sterile Processing Department Labor and Capacity Constraints
3.1.5. Demand for Consistent Instrument Performance and Immediate Availability
3.1.6. Procedure Standardization and Growth of Preconfigured Surgical Kits
3.1.7. Rising Surgical Volumes Driven by an Aging U.S. Population
3.2. Restraints and Their Impact Analysis
3.2.1. Higher Per-Procedure Acquisition Cost for Selected Disposable Instruments
3.2.2. Environmental and Medical Waste Concerns
3.2.3. Established Hospital Investment in Reusable Instrument Fleets
3.2.4. Surgeon Preference for Premium Reusable Instrument Ergonomics
3.2.5. GPO Pricing Pressure and Commoditization of Basic Instruments
3.3. Opportunities and Their Impact Analysis
3.3.1. Single-Use Powered Surgical Instruments
3.3.2. Disposable Electrosurgical and Advanced Energy Instruments
3.3.3. Single-Use Digital Visualization and Smart Instruments
3.3.4. Procedure-Specific Disposable Instrument Kits
3.3.5. ASC and Office-Based Surgical Expansion
3.3.6. Sustainable Single-Use Instrument Materials and Recycling Models
3.3.7. Private-Label and OEM Manufacturing Opportunities
3.4. Challenges and Their Impact Analysis
3.4.1. Balancing Sterility Benefits with Sustainability Objectives
3.4.2. Supply Chain Resilience and Sterilization Capacity
3.4.3. Clinical Conversion from Reusable Instrument Platforms
3.4.4. Demonstrating Total Cost-of-Ownership Advantage
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Sterile Processing Cost and Capacity Analysis
3.8. Hospital and ASC Procurement Behavior Analysis
3.9. Reusable-to-Single-Use Conversion Analysis
What this section provides: This section explains the clinical, operational, economic, sustainability, and procurement forces shaping single-use instrument demand and helps clients evaluate market upside, adoption barriers, conversion potential, and execution risks.

4. U.S. Single-Use Surgical Instruments Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk from Reusable and Reprocessed Instruments
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Raw Material and Component Supply Analysis
4.6. Contract Manufacturing and Sterilization Landscape
4.7. Packaging Integrity and Sterile Barrier System Analysis
4.8. Application & Innovation Landscape
4.9. Sustainability, Waste and Lifecycle Assessment Landscape
4.10. FDA Regulatory Framework Analysis
4.11. FDA Quality Management System Regulation Impact
4.12. CMS Reimbursement and Outpatient Surgical Environment
4.13. Single-Use Device Reprocessing Regulatory Landscape
4.14. Import/Export Restrictions & Tariff Impact
4.15. Government Healthcare and Infection Prevention Initiatives
4.16. Impact of Escalating Geopolitical and Supply Chain Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. Single-Use versus Reusable Total Cost-of-Ownership Framework
What this section provides: This section provides a complete view of regulation, reimbursement, pricing, supply chains, sterilization, sustainability, technology development, and hospital procurement criteria influencing the U.S. single-use surgical instruments industry.

5. U.S. Single-Use Surgical Instruments Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Handheld Single-Use Surgical Instruments
5.1.2.1. Scalpels and Surgical Blades
5.1.2.2. Surgical Scissors
5.1.2.3. Forceps and Graspers
5.1.2.4. Clamps
5.1.2.5. Needle Holders
5.1.2.6. Retractors
5.1.2.7. Curettes and Dissectors
5.1.2.8. Biopsy and Specialty Handheld Instruments
5.1.3. Single-Use Electrosurgical Instruments
5.1.3.1. Electrosurgical Pencils
5.1.3.2. Monopolar Instruments
5.1.3.3. Bipolar Forceps
5.1.3.4. Vessel-Sealing Instruments
5.1.3.5. Laparoscopic Energy Instruments
5.1.4. Single-Use Laparoscopic and Endoscopic Instruments
5.1.4.1. Trocars and Access Devices
5.1.4.2. Laparoscopic Graspers
5.1.4.3. Laparoscopic Scissors and Dissectors
5.1.4.4. Suction-Irrigation Instruments
5.1.4.5. Retrieval Instruments
5.1.4.6. Endoscopic Biopsy and Specialty Instruments
5.1.5. Single-Use Powered Surgical Instruments
5.1.5.1. Surgical Drills
5.1.5.2. Surgical Saws
5.1.5.3. Wire and Pin Drivers
5.1.5.4. Battery-Powered Specialty Instruments
5.1.6. Specialty Single-Use Surgical Instruments and Procedure Kits
5.1.6.1. Ophthalmic Instruments
5.1.6.2. ENT Instruments
5.1.6.3. Gynecological Instruments
5.1.6.4. Orthopedic Specialty Instruments
5.1.6.5. Microsurgical Instruments
5.1.6.6. Procedure-Specific Disposable Instrument Sets
What this section provides: This section identifies which single-use surgical instrument categories are expected to generate the largest revenue contribution and strongest growth, while highlighting emerging premium opportunities in energy, minimally invasive, powered, and specialty disposable instruments.

6. U.S. Single-Use Surgical Instruments Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. General Surgery
6.1.2.1. Gastrointestinal Surgery
6.1.2.2. Hernia Repair
6.1.2.3. Bariatric Surgery
6.1.2.4. Colorectal Surgery
6.1.2.5. Hepatobiliary Surgery
6.1.3. Orthopedic Surgery
6.1.3.1. Joint and Bone Procedures
6.1.3.2. Trauma Surgery
6.1.3.3. Sports Medicine and Arthroscopy
6.1.3.4. Extremity Procedures
6.1.4. Cardiovascular and Thoracic Surgery
6.1.4.1. Cardiac Surgery
6.1.4.2. Vascular Surgery
6.1.4.3. Thoracic Surgery
6.1.5. Obstetrics and Gynecology
6.1.5.1. Laparoscopic Gynecologic Surgery
6.1.5.2. Hysteroscopic Procedures
6.1.5.3. Obstetric Surgical Procedures
6.1.5.4. Other Women’s Health Procedures
6.1.6. Urology
6.1.6.1. Kidney and Stone Procedures
6.1.6.2. Bladder Procedures
6.1.6.3. Prostate Procedures
6.1.6.4. Minimally Invasive Urologic Surgery
6.1.7. Ophthalmology
6.1.8. ENT Surgery
6.1.9. Plastic and Reconstructive Surgery
6.1.10. Other Surgical Applications
What this section provides: This section evaluates single-use instrument demand by clinical procedure category and identifies applications with strong surgical volumes, outpatient migration, infection-prevention requirements, and reusable-to-disposable conversion potential.

7. U.S. Single-Use Surgical Instruments Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Health Systems
7.1.2.1. Large Integrated Delivery Networks
7.1.2.2. Academic and Tertiary Care Hospitals
7.1.2.3. Community Hospitals
7.1.2.4. Rural and Critical Access Hospitals
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Hospital-Owned ASCs
7.1.3.2. Independent ASCs
7.1.3.3. Physician-Owned ASCs
7.1.4. Specialty Surgical Hospitals and Centers
7.1.4.1. Orthopedic Surgical Centers
7.1.4.2. Ophthalmic Surgical Centers
7.1.4.3. Women’s Health Surgical Centers
7.1.4.4. ENT and Specialty Procedure Centers
7.1.5. Office-Based Procedure Centers and Physician Practices
7.1.6. Emergency and Urgent Surgical Care Facilities
What this section provides: This section explains which U.S. care settings are driving single-use surgical instrument purchasing and identifies differences in procurement economics, sterile-processing infrastructure, procedure throughput, and disposable adoption across hospitals and outpatient facilities.

8. U.S. Single-Use Surgical Instruments Market – By Technology & Instrument Configuration

8.1. Overview
8.1.1. Segment Share Analysis, By Technology & Instrument Configuration, 2025 & 2035 (%)
8.1.2. Conventional Mechanical Single-Use Instruments
8.1.3. Energy-Based Single-Use Instruments
8.1.3.1. Monopolar Technology
8.1.3.2. Bipolar Technology
8.1.3.3. Advanced Vessel-Sealing Technology
8.1.4. Minimally Invasive and Articulating Single-Use Instruments
8.1.5. Battery-Powered and Powered Single-Use Instruments
8.1.6. Digitally Enabled and Visualization-Integrated Single-Use Instruments
8.1.7. Smart and Sensor-Enabled Emerging Instruments
8.1.8. Preconfigured Procedure-Specific Instrument Kits
What this section provides: This section evaluates technology platforms reshaping disposable surgical instrumentation, from conventional mechanical tools to advanced energy, powered devices, digital visualization, articulation, smart instrumentation, and procedure-specific configurations.

9. U.S. Single-Use Surgical Instruments Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Manufacturer Sales
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.5. Medical-Surgical Distributor Sales
9.1.6. Specialty Distributor Sales
9.1.7. Private-Label and OEM Supply Agreements
9.1.8. ASC and Office-Based Direct Procurement
What this section provides: This section explains how single-use surgical instruments are purchased across the U.S., including IDN standardization, GPO contracting, distributor influence, private-label sourcing, direct manufacturer relationships, and outpatient purchasing behavior.

10. U.S. Single-Use Surgical Instruments Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Surgical Procedure Volume Analysis
10.1.4. Hospital and ASC Infrastructure Analysis
10.1.5. Regional Sterile Processing and Single-Use Conversion Dynamics
10.1.6. Regional Procurement, GPO and Distributor Landscape
10.1.7. Regional Sustainability and Medical Waste Considerations
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Distributors and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Distributors and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Distributors and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Distributors and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology & Instrument Configuration, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis across all four U.S. regions, helping clients identify priority geographies, surgical-volume hubs, ASC growth markets, reusable-to-single-use conversion opportunities, procurement hotspots, and state-level commercial potential.

11. U.S. Single-Use Surgical Instruments Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Product Portfolio Breadth
11.2.2. U.S. Hospital and ASC Penetration
11.2.3. GPO and IDN Contracting Strength
11.2.4. Single-Use Technology Innovation
11.2.5. Manufacturing and Sterilization Capabilities
11.2.6. Sustainability Positioning
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Johnson & Johnson MedTech – Ethicon
11.4.2. Medtronic
11.4.3. BD
11.4.4. B. Braun
11.4.5. Stryker
11.4.6. Smith+Nephew
11.4.7. CONMED Corporation
11.4.8. CooperSurgical
11.4.9. Alcon
11.4.10. STERIS
11.4.11. Aspen Surgical
11.4.12. Integra LifeSciences
11.4.13. Teleflex
11.4.14. Olympus Corporation
11.4.15. Boston Scientific Corporation
11.4.16. Applied Medical Resources
11.4.17. Medline Industries
11.4.18. Cardinal Health
11.4.19. Sklar Surgical Instruments
11.4.20. Kirwan Surgical Products
11.4.21. DTR Medical
11.4.22. Surgical Innovations Group
11.4.23. Pristine Surgical
11.4.24. Peleton Surgical
11.4.25. Swann-Morton
Note: Each company profile will include company overview, single-use surgical instrument portfolio, U.S. market strategy, product positioning, manufacturing and sterilization capabilities, distribution footprint, hospital/ASC presence, regulatory developments, partnerships, acquisitions, innovation pipeline, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, product portfolio positioning, innovation direction, contracting strength, and strategic intelligence on leading and emerging participants in the U.S. single-use surgical instruments market.

12. U.S. Single-Use Surgical Instruments Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Reusable-to-Single-Use Conversion Outlook
12.2.1. High-Probability Conversion Categories
12.2.2. Moderate-Probability Conversion Categories
12.2.3. Reusable-Dominant Categories
12.3. Disruptive Technologies Impact
12.3.1. Single-Use Powered Surgical Systems
12.3.2. Advanced Disposable Electrosurgical Instruments
12.3.3. Single-Use Digital Visualization Systems
12.3.4. Smart and Sensor-Enabled Surgical Instruments
12.3.5. Advanced Polymers and Lightweight Materials
12.3.6. Sustainable Packaging and Recycling Technologies
12.4. Outpatient and ASC Surgical Migration Outlook
12.5. Sterile Processing Capacity Outlook
12.6. Sustainability and Medical Waste Outlook
12.7. Emerging Business Models
12.7.1. Procedure-Based Supply Contracts
12.7.2. Private-Label Manufacturing
12.7.3. Instrument Kit Standardization
12.7.4. Take-Back and Recycling Programs
12.7.5. Digital Inventory and Usage Management
12.8. Business Opportunities for Startups and Existing Players
12.9. Investment Prioritization Matrix
What this section provides: This section prepares clients for future changes in surgical workflows, reusable-to-disposable conversion, ASC migration, powered and digital instrument technology, sustainability requirements, emerging business models, and investment opportunities through 2035.

13. U.S. Single-Use Surgical Instruments Market: Strategic Recommendations

13.1. Recommendations for Single-Use Surgical Instrument Manufacturers
13.1.1. Target High-Value Reusable-to-Single-Use Conversion Categories
13.1.2. Build Procedure-Level Health Economic Evidence
13.1.3. Strengthen ASC-Specific Product Portfolios
13.1.4. Develop Sustainable Product and Packaging Strategies
13.2. Recommendations for Hospitals and Health Systems
13.2.1. Total Cost-of-Ownership Assessment
13.2.2. Sterile Processing Capacity Assessment
13.2.3. Clinical Standardization and Value Analysis
13.2.4. Waste and Sustainability Assessment
13.3. Recommendations for Ambulatory Surgery Centers
13.3.1. Procedure-Level Disposable Instrument Standardization
13.3.2. Inventory and Room-Turnover Optimization
13.3.3. Vendor Consolidation Strategy
13.4. Recommendations for Investors and Private Equity Firms
13.4.1. High-Growth Product Categories
13.4.2. Specialty Manufacturer Acquisition Opportunities
13.4.3. Contract Manufacturing and Sterilization Opportunities
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.8. GPO and IDN Contracting Strategy
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. U.S. State-Level Commercial Prioritization Strategy
What this section provides: This section converts market intelligence into actionable recommendations for manufacturing strategy, hospital conversion, ASC penetration, investment planning, channel development, product positioning, contracting, sustainability, and geographic expansion.

14. U.S. Single-Use Surgical Instruments Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Market Definition Limitation
14.5. Regulatory and Reimbursement Limitation
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s scope, market-definition boundaries, data-use terms, regulatory assumptions, forecasting limitations, third-party data considerations, and legal conditions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Single-Use Surgical Instruments Market: Market Definition and Scope
TABLE 3: U.S. Single-Use Surgical Instruments Market: Research Methodology Framework
TABLE 4: U.S. Single-Use Surgical Instruments Market: Key Assumptions
TABLE 5: U.S. Single-Use Surgical Instruments Market: Market Ecosystem Overview
TABLE 6: U.S. Single-Use Surgical Instruments Market: Stakeholder Analysis
TABLE 7: U.S. Single-Use Surgical Instruments Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Single-Use Surgical Instruments Market: Analyst Viewpoint Summary
TABLE 9: U.S. Single-Use Surgical Instruments Market: Market Attractiveness Index
TABLE 10: U.S. Single-Use Surgical Instruments Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Single-Use Surgical Instruments Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Single-Use Surgical Instruments Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Single-Use Surgical Instruments Market: Single-Use vs. Reusable Instrument Economics
TABLE 14: U.S. Single-Use Surgical Instruments Market: High-Growth Opportunity Areas
TABLE 15: U.S. Single-Use Surgical Instruments Market: Drivers; Impact Analysis
TABLE 16: U.S. Single-Use Surgical Instruments Market: Restraints; Impact Analysis
TABLE 17: U.S. Single-Use Surgical Instruments Market: Opportunities; Impact Analysis
TABLE 18: U.S. Single-Use Surgical Instruments Market: Challenges; Impact Analysis
TABLE 19: U.S. Single-Use Surgical Instruments Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Single-Use Surgical Instruments Market: Clinical Workflow Economics Matrix
TABLE 21: U.S. Single-Use Surgical Instruments Market: Sterile Processing Cost and Capacity Matrix
TABLE 22: U.S. Single-Use Surgical Instruments Market: Hospital and ASC Procurement Behavior Matrix
TABLE 23: U.S. Single-Use Surgical Instruments Market: Reusable-to-Single-Use Conversion Matrix
TABLE 24: U.S. Single-Use Surgical Instruments Market: PESTEL Analysis
TABLE 25: U.S. Single-Use Surgical Instruments Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Single-Use Surgical Instruments Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Single-Use Surgical Instruments Market: Value Chain Analysis
TABLE 28: U.S. Single-Use Surgical Instruments Market: Supply Chain Analysis
TABLE 29: U.S. Single-Use Surgical Instruments Market: Contract Manufacturing and Sterilization Landscape
TABLE 30: U.S. Single-Use Surgical Instruments Market: Packaging and Sterile Barrier System Analysis
TABLE 31: U.S. Single-Use Surgical Instruments Market: Application & Innovation Landscape
TABLE 32: U.S. Single-Use Surgical Instruments Market: Sustainability and Medical Waste Landscape
TABLE 33: U.S. Single-Use Surgical Instruments Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Single-Use Surgical Instruments Market: FDA Quality Management System Regulation Impact
TABLE 35: U.S. Single-Use Surgical Instruments Market: CMS and Outpatient Surgical Environment
TABLE 36: U.S. Single-Use Surgical Instruments Market: Single-Use Device Reprocessing Regulatory Landscape
TABLE 37: U.S. Single-Use Surgical Instruments Market: Import/Export Restrictions & Tariff Impact
TABLE 38: U.S. Single-Use Surgical Instruments Market: Geopolitical and Supply Chain Risk Analysis
TABLE 39: U.S. Single-Use Surgical Instruments Market: Hospital Value Analysis Committee Decision Framework
TABLE 40: U.S. Single-Use Surgical Instruments Market: Total Cost-of-Ownership Framework
TABLE 41: U.S. Single-Use Surgical Instruments Market: Product Type Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Type
TABLE 43: U.S. Single-Use Surgical Instruments Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 44: U.S. Single-Use Surgical Instruments Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 45: Handheld Single-Use Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: Single-Use Electrosurgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: Single-Use Laparoscopic and Endoscopic Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Single-Use Powered Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Specialty Single-Use Surgical Instruments and Procedure Kits Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Single-Use Surgical Instruments Market: Application Snapshot, 2025
TABLE 51: Segment Dashboard; Definition and Scope, by Application
TABLE 52: U.S. Single-Use Surgical Instruments Market, by Application, 2021–2035 (US$ Billion)
TABLE 53: U.S. Single-Use Surgical Instruments Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 54: General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Cardiovascular and Thoracic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: Obstetrics and Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Urology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Ophthalmology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: ENT Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Plastic, Reconstructive and Other Surgical Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Single-Use Surgical Instruments Market: End User Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by End User
TABLE 64: U.S. Single-Use Surgical Instruments Market, by End User, 2021–2035 (US$ Billion)
TABLE 65: U.S. Single-Use Surgical Instruments Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 66: Hospitals and Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Specialty Surgical Hospitals and Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Office-Based Procedure Centers and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Emergency and Urgent Surgical Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Single-Use Surgical Instruments Market: Technology & Instrument Configuration Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by Technology & Instrument Configuration
TABLE 73: U.S. Single-Use Surgical Instruments Market, by Technology & Instrument Configuration, 2021–2035 (US$ Billion)
TABLE 74: U.S. Single-Use Surgical Instruments Market: Segment Share Analysis, by Technology & Instrument Configuration, 2025 & 2035 (%)
TABLE 75: Conventional Mechanical Single-Use Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Energy-Based Single-Use Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Minimally Invasive and Articulating Single-Use Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: Powered Single-Use Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Digitally Enabled and Visualization-Integrated Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Smart, Sensor-Enabled and Procedure-Specific Instrument Configurations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Single-Use Surgical Instruments Market: Procurement Channel Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 83: U.S. Single-Use Surgical Instruments Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 84: U.S. Single-Use Surgical Instruments Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 85: Direct Manufacturer Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Medical-Surgical and Specialty Distributor Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Private-Label, OEM, ASC and Office-Based Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Single-Use Surgical Instruments Market: Regional Snapshot, 2025
TABLE 91: Segment Dashboard; Definition and Scope, by Geography
TABLE 92: U.S. Single-Use Surgical Instruments Market, by Region, 2021–2035 (US$ Billion)
TABLE 93: U.S. Single-Use Surgical Instruments Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 94: West Region U.S. Single-Use Surgical Instruments Market: Regional Overview and Trends
TABLE 95: West Region U.S. Single-Use Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 96: West Region U.S. Single-Use Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Single-Use Surgical Instruments Market, by Product Type, Application, End User, Technology and Procurement Channel, 2021–2035
TABLE 98: California Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 99: Washington Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 100: Arizona Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 101: Colorado Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 102: Oregon Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 103: Utah Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 104: Nevada Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 105: New Mexico Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 106: Idaho Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 107: Montana Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 108: Wyoming Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 109: Alaska Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 110: Hawaii Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 111: Northeast Region U.S. Single-Use Surgical Instruments Market: Regional Overview and Trends
TABLE 112: Northeast Region U.S. Single-Use Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 113: Northeast Region U.S. Single-Use Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Single-Use Surgical Instruments Market, by Product Type, Application, End User, Technology and Procurement Channel, 2021–2035
TABLE 115: New York Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 116: Massachusetts Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 117: New Jersey Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 118: Pennsylvania Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 119: Connecticut Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 120: Maine Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 121: Vermont Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 122: New Hampshire Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 123: Rhode Island Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 124: Delaware Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 125: South Region U.S. Single-Use Surgical Instruments Market: Regional Overview and Trends
TABLE 126: South Region U.S. Single-Use Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 127: South Region U.S. Single-Use Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Single-Use Surgical Instruments Market, by Product Type, Application, End User, Technology and Procurement Channel, 2021–2035
TABLE 129: Texas Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 130: Florida Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 131: Georgia Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 132: North Carolina Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 133: Tennessee Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 134: South Carolina Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 135: Alabama Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 136: Mississippi Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 137: Louisiana Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 138: Arkansas Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 139: Kentucky Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 140: Oklahoma Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 141: Virginia Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 142: Maryland Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 143: West Virginia Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 144: Midwest Region U.S. Single-Use Surgical Instruments Market: Regional Overview and Trends
TABLE 145: Midwest Region U.S. Single-Use Surgical Instruments Market: Key Manufacturers, Distributors and Procurement Ecosystem
TABLE 146: Midwest Region U.S. Single-Use Surgical Instruments Market, by State, 2021–2035 (US$ Billion)
TABLE 147: Midwest Region U.S. Single-Use Surgical Instruments Market, by Product Type, Application, End User, Technology and Procurement Channel, 2021–2035
TABLE 148: Illinois Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 149: Ohio Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 150: Michigan Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 151: Minnesota Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 152: Indiana Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 153: Wisconsin Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 154: Missouri Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 155: Iowa Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 156: Kansas Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 157: Nebraska Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 158: North Dakota Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 159: South Dakota Single-Use Surgical Instruments Market, 2021–2035 (US$ Billion)
TABLE 160: U.S. Single-Use Surgical Instruments Market: Competitive Landscape Snapshot, 2025
TABLE 161: U.S. Single-Use Surgical Instruments Market: Key Company Market Share Analysis, 2025
TABLE 162: U.S. Single-Use Surgical Instruments Market: Competitive Benchmarking Matrix
TABLE 163: U.S. Single-Use Surgical Instruments Market: Company Positioning Matrix
TABLE 164: U.S. Single-Use Surgical Instruments Market: Product Portfolio Benchmarking of Key Players
TABLE 165: U.S. Single-Use Surgical Instruments Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 166: Johnson & Johnson MedTech – Ethicon: Company Profile
TABLE 167: Medtronic: Company Profile
TABLE 168: BD: Company Profile
TABLE 169: B. Braun: Company Profile
TABLE 170: Stryker: Company Profile
TABLE 171: Smith+Nephew: Company Profile
TABLE 172: CONMED Corporation: Company Profile
TABLE 173: CooperSurgical: Company Profile
TABLE 174: Alcon: Company Profile
TABLE 175: STERIS: Company Profile
TABLE 176: Aspen Surgical: Company Profile
TABLE 177: Integra LifeSciences: Company Profile
TABLE 178: Teleflex: Company Profile
TABLE 179: Olympus Corporation: Company Profile
TABLE 180: Boston Scientific Corporation: Company Profile
TABLE 181: Applied Medical Resources: Company Profile
TABLE 182: Medline Industries: Company Profile
TABLE 183: Cardinal Health: Company Profile
TABLE 184: Sklar Surgical Instruments: Company Profile
TABLE 185: Kirwan Surgical Products: Company Profile
TABLE 186: DTR Medical: Company Profile
TABLE 187: Surgical Innovations Group: Company Profile
TABLE 188: Pristine Surgical: Company Profile
TABLE 189: Peleton Surgical: Company Profile
TABLE 190: Swann-Morton: Company Profile
TABLE 191: U.S. Single-Use Surgical Instruments Market: Future Market Scenario Analysis, 2026–2035
TABLE 192: U.S. Single-Use Surgical Instruments Market: Reusable-to-Single-Use Conversion Outlook
TABLE 193: U.S. Single-Use Surgical Instruments Market: Disruptive Technologies Impact Matrix
TABLE 194: U.S. Single-Use Surgical Instruments Market: ASC and Outpatient Surgical Migration Outlook
TABLE 195: U.S. Single-Use Surgical Instruments Market: Sterile Processing Capacity Outlook
TABLE 196: U.S. Single-Use Surgical Instruments Market: Sustainability and Medical Waste Outlook
TABLE 197: U.S. Single-Use Surgical Instruments Market: Emerging Business Models
TABLE 198: U.S. Single-Use Surgical Instruments Market: Business Opportunities for Startups and Existing Players
TABLE 199: U.S. Single-Use Surgical Instruments Market: Investment Prioritization Matrix
TABLE 200: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for Manufacturers
TABLE 201: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 202: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 203: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 204: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 205: U.S. Single-Use Surgical Instruments Market: Strategic Recommendations for New Entrants and Startups
TABLE 206: U.S. Single-Use Surgical Instruments Market: Go-to-Market and GPO/IDN Contracting Strategy
TABLE 207: U.S. Single-Use Surgical Instruments Market: Product Positioning and Portfolio Expansion Guidance
TABLE 208: U.S. Single-Use Surgical Instruments Market: U.S. State-Level Commercial Prioritization Matrix
TABLE 209: U.S. Single-Use Surgical Instruments Market: Scope Limitation
TABLE 210: U.S. Single-Use Surgical Instruments Market: Data Use Limitation
TABLE 211: U.S. Single-Use Surgical Instruments Market: Forecasting Limitation
TABLE 212: U.S. Single-Use Surgical Instruments Market: Market Definition Limitation
TABLE 213: U.S. Single-Use Surgical Instruments Market: Regulatory and Reimbursement Limitation
TABLE 214: U.S. Single-Use Surgical Instruments Market: Legal Disclaimer
TABLE 215: U.S. Single-Use Surgical Instruments Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Single-Use Surgical Instruments Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: U.S. Single-Use Surgical Instruments Market Attractiveness Analysis
FIGURE 5: Historical Market Size Trend, 2021–2024 (US$ Billion)
FIGURE 6: Market Size Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Single-Use Surgical Instruments Market Year-wise Growth Curve, 2021–2035
FIGURE 8: Single-Use versus Reusable Surgical Instrument Economics Framework
FIGURE 9: U.S. Single-Use Surgical Instruments Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Sterile Processing Cost and Capacity Framework
FIGURE 13: Hospital and ASC Procurement Decision Framework
FIGURE 14: Reusable-to-Single-Use Conversion Opportunity Matrix
FIGURE 15: PESTEL Analysis
FIGURE 16: Porter’s Five Forces Analysis
FIGURE 17: Value Chain Analysis
FIGURE 18: Supply Chain and Sterilization Ecosystem
FIGURE 19: Sustainability and Medical Waste Impact Framework
FIGURE 20: FDA Regulatory and Quality Management Framework
FIGURE 21: Hospital Value Analysis Committee Decision Framework
FIGURE 22: Total Cost-of-Ownership Comparison Framework
FIGURE 23: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Handheld Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 26: Single-Use Electrosurgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 27: Single-Use Laparoscopic and Endoscopic Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 28: Single-Use Powered Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 29: Specialty Instruments and Procedure Kits Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 30: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 31: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: General Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Orthopedic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Cardiovascular and Thoracic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Obstetrics and Gynecology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Urology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Ophthalmology, ENT and Other Specialty Applications Growth Analysis, 2021–2035
FIGURE 38: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 39: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Hospitals and Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Specialty Surgical Hospitals and Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Office-Based and Other Surgical Facilities Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 44: Technology & Instrument Configuration Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Technology & Instrument Configuration Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 46: Conventional Mechanical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 47: Energy-Based Single-Use Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 48: Minimally Invasive and Articulating Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 49: Powered and Digitally Enabled Single-Use Instruments Growth Outlook, 2021–2035
FIGURE 50: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Procurement Channel Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Direct Manufacturer and IDN Enterprise Contracting Outlook, 2021–2035
FIGURE 53: GPO and Distributor Procurement Outlook, 2021–2035
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Single-Use Surgical Instruments Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 60: Washington Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 64: Utah Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 67: Idaho, Montana, Wyoming, Alaska and Hawaii Market Growth Comparison, 2021–2035
FIGURE 68: Northeast Region U.S. Single-Use Surgical Instruments Market Share and Leading Players, 2025
FIGURE 69: Northeast Region Market Share Analysis by State, 2025
FIGURE 70: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: New York Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 72: Massachusetts Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 73: New Jersey Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 74: Pennsylvania Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 75: Connecticut Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 76: Maine, Vermont, New Hampshire, Rhode Island and Delaware Market Growth Comparison, 2021–2035
FIGURE 77: South Region U.S. Single-Use Surgical Instruments Market Share and Leading Players, 2025
FIGURE 78: South Region Market Share Analysis by State, 2025
FIGURE 79: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Texas Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 81: Florida Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 82: Georgia Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 83: North Carolina Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 84: Tennessee Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 85: South Carolina Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 86: Alabama, Mississippi and Louisiana Market Growth Comparison, 2021–2035
FIGURE 87: Arkansas, Kentucky and Oklahoma Market Growth Comparison, 2021–2035
FIGURE 88: Virginia, Maryland and West Virginia Market Growth Comparison, 2021–2035
FIGURE 89: Midwest Region U.S. Single-Use Surgical Instruments Market Share and Leading Players, 2025
FIGURE 90: Midwest Region Market Share Analysis by State, 2025
FIGURE 91: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Illinois Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 93: Ohio Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 94: Michigan Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 95: Minnesota Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 96: Indiana Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 97: Wisconsin Single-Use Surgical Instruments Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 98: Missouri and Iowa Single-Use Surgical Instruments Market Growth Comparison, 2021–2035
FIGURE 99: Kansas and Nebraska Single-Use Surgical Instruments Market Growth Comparison, 2021–2035
FIGURE 100: North Dakota and South Dakota Single-Use Surgical Instruments Market Growth Comparison, 2021–2035
FIGURE 101: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 102: Company Positioning Matrix
FIGURE 103: Key Player Product Portfolio Benchmarking
FIGURE 104: U.S. Hospital, ASC and Distribution Channel Competitive Positioning
FIGURE 105: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 106: Single-Use Surgical Instrument Innovation Roadmap
FIGURE 107: Reusable-to-Single-Use Conversion Roadmap
FIGURE 108: Powered Single-Use Surgical Instruments Opportunity Map
FIGURE 109: Disposable Electrosurgical and Minimally Invasive Technology Roadmap
FIGURE 110: Digital Visualization and Smart Instrument Opportunity Map
FIGURE 111: Future Market Scenario Analysis, 2026–2035
FIGURE 112: Disruptive Technologies Impact Matrix
FIGURE 113: ASC and Outpatient Surgical Migration Roadmap
FIGURE 114: Sterile Processing Capacity and Single-Use Adoption Relationship
FIGURE 115: Sustainability and Medical Waste Strategy Framework
FIGURE 116: Emerging Business Models Matrix
FIGURE 117: Investment Prioritization Matrix
FIGURE 118: Strategic Growth Roadmap for U.S. Single-Use Surgical Instrument Manufacturers
FIGURE 119: Hospital and ASC Conversion Strategy Framework
FIGURE 120: GPO, IDN and Distributor Go-to-Market Strategy Framework
FIGURE 121: Product Positioning and Portfolio Expansion Framework
FIGURE 122: U.S. State-Level Commercial Opportunity Map
FIGURE 123: Strategic Recommendations Framework
FIGURE 124: Report Scope, Market Definition and Disclaimer Framework